Yentli Soto Albrecht, who is a genetic carrier of ALS, is working on research at Penn that could one day prove life-saving.

Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced new open-label extension study data for repinatrabit (JNT-517), demonstrating ...

New research advances genetic diagnosisDemonstrates the potential to expand equitable access to treatment for patients living with rare inherited metabolic and neurodegenerative diseasesBALTIMORE ...

AM ET at the Baltimore Convention Center, the ACMG Foundation will join genetics professionals from around the world to present customized adaptive bicycles to children receiving care at Kennedy ...

Researchers at VIB and Antwerp University have identified a major genetic risk factor for a rare form of frontotemporal ...

Cancer is caused by faulty genes, but what also shapes a cancer cell's behavior is how a gene's instructions are trimmed and ...

Medical case study: doctors navigated complex risks and used a tailored treatment strategy to successfully transplant a kidney from the patient's elder brother.

Ratio Therapeutics Inc. (Ratio), a pharmaceutical company employing innovative technologies to develop best-in-class radiopharmaceuticals for cancer treatment and monitoring, today announced the ...

Now, a step forward in genetic testing could help doctors look deeper than ever before to predict a patient's future health. In a series of studies published recently in Bone Marrow Transplantation, ...

An insightful mini-review published in Genomic Psychiatry synthesizes the rapidly expanding landscape of molecular genetic research on common epilepsies, assembling evidence from genome-wide ...